
The retrospective study explored the efficacy of once-weekly compounded semaglutide/cyanocobalamin injections for weight loss and body composition changes in a commercial wellness setting. Over three months, 94 participants (81F/13M, mean age 46.57) experienced an average weight loss of 4.11 kg (4.57%). Fat mass decreased, while lean and skeletal muscle mass showed modest increases. The results indicate that semaglutide/cyanocobalamin is effective for weight loss and improving body composition outside controlled clinical environments.
Like
Save
Share